Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Weissman NJ, Fearnot NE, Park SW, Park SJ; ASian Paclitaxel-Eluting Stent Clinical Trial. Hong MK, et al. Among authors: fearnot ne. Circulation. 2003 Feb 4;107(4):517-20. doi: 10.1161/01.cir.0000054163.42072.d4. Circulation. 2003. PMID: 12566359 Clinical Trial.
Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Mintz GS, Tinana A, Hong MK, Lee CW, Kim JJ, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Among authors: fearnot ne. Circulation. 2003 Sep 16;108(11):1295-8. doi: 10.1161/01.CIR.0000091254.73351.D6. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952833 Clinical Trial.
Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Among authors: fearnot ne. Am J Cardiol. 2005 Jan 1;95(1):105-7. doi: 10.1016/j.amjcard.2004.08.071. Am J Cardiol. 2005. PMID: 15619403 Clinical Trial.
Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Among authors: fearnot ne. Am J Cardiol. 2005 Jan 1;95(1):107-9. doi: 10.1016/j.amjcard.2004.08.072. Am J Cardiol. 2005. PMID: 15619404 Clinical Trial.
Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials).
Kałuza GL, Gershlick AH, Park SJ, De Scheerder I, Chevalier B, Camenzind E, Goy JJ, Missault L, Reifart N, Vrints C, Urban P, Shim WH, Ho DS, Fearnot NE, Voorhees WD 3rd, Raizner AE. Kałuza GL, et al. Among authors: fearnot ne. Am J Cardiol. 2004 Jul 15;94(2):199-201. doi: 10.1016/j.amjcard.2004.03.063. Am J Cardiol. 2004. PMID: 15246901
Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes.
George BS, Voorhees WD 3rd, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB, Holmes DR, Topol EJ, Kereiakes DJ, et al. George BS, et al. Among authors: fearnot ne. J Am Coll Cardiol. 1993 Jul;22(1):135-43. doi: 10.1016/0735-1097(93)90827-n. J Am Coll Cardiol. 1993. PMID: 8509533 Free article. Clinical Trial.
45 results